Literature DB >> 22310848

Pharmacotherapy: statins and new-onset diabetes mellitus--a matter for debate.

Vassilios G Athyros, Dimitri P Mikhailidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22310848     DOI： 10.1038/nrendo.2012.16

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis.

Authors:  Asterios Karagiannis; Konstantinos Tziomalos; Panagiotis Anagnostis; Thomas D Gossios; Matilda Florentin; Vasilios G Athyros; Dimitri P Mikhailidis
Journal:  Curr Vasc Pharmacol       Date:  2010-11       Impact factor: 2.719

2.  Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.

Authors:  Vassilios G Athyros; Moses S Elisaf; Theodore Alexandrides; Apostolos Achimastos; Emmanouel Ganotakis; Eleni Bilianou; Asterios Karagiannis; Evangelos N Liberopoulos; Konstantinos Tziomalos; Dimitri P Mikhailidis
Journal:  Angiology       Date:  2011-10-17       Impact factor: 3.619

3.  Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials.

Authors:  David D Waters; Jennifer E Ho; David A DeMicco; Andrei Breazna; Benoit J Arsenault; Chuan-Chuan Wun; John J Kastelein; Helen Colhoun; Philip Barter
Journal:  J Am Coll Cardiol       Date:  2011-04-05       Impact factor: 24.094

4.  Lipid-lowering agents and new onset diabetes mellitus.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Expert Opin Pharmacother       Date:  2010-08       Impact factor: 3.889

5.  Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).

Authors:  H Andrew W Neil; David A DeMicco; Don Luo; D John Betteridge; Helen M Colhoun; Paul N Durrington; Shona J Livingstone; John H Fuller; Graham A Hitman
Journal:  Diabetes Care       Date:  2006-11       Impact factor: 19.112

Review 6.  Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

7.  Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative.

Authors:  Annie L Culver; Ira S Ockene; Raji Balasubramanian; Barbara C Olendzki; Deidre M Sepavich; Jean Wactawski-Wende; Joann E Manson; Yongxia Qiao; Simin Liu; Philip A Merriam; Catherine Rahilly-Tierny; Fridtjof Thomas; Jeffrey S Berger; Judith K Ockene; J David Curb; Yunsheng Ma
Journal:  Arch Intern Med       Date:  2012-01-09

8.  Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

Authors:  David Preiss; Sreenivasa Rao Kondapally Seshasai; Paul Welsh; Sabina A Murphy; Jennifer E Ho; David D Waters; David A DeMicco; Philip Barter; Christopher P Cannon; Marc S Sabatine; Eugene Braunwald; John J P Kastelein; James A de Lemos; Michael A Blazing; Terje R Pedersen; Matti J Tikkanen; Naveed Sattar; Kausik K Ray
Journal:  JAMA       Date:  2011-06-22       Impact factor: 56.272

9.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

10.  Adverse prognostic significance of new diabetes in treated hypertensive subjects.

Authors:  Paolo Verdecchia; Gianpaolo Reboldi; Fabio Angeli; Claudia Borgioni; Roberto Gattobigio; Lucia Filippucci; Silvia Norgiolini; Costanza Bracco; Carlo Porcellati
Journal:  Hypertension       Date:  2004-03-22       Impact factor: 10.190
  10 in total
  4 in total

1.  Therapy: Caloric and fat intake in statin users.

Authors:  Vasilios G Athyros; Dimitri P Mikhailidis
Journal:  Nat Rev Endocrinol       Date:  2014-06-03       Impact factor: 43.330

2.  Prevalence of type 2 diabetes mellitus compared between lean and overweight/obese patients with polycystic ovarian syndrome: a 5-year follow-up study.

Authors:  Panicha Chantrapanichkul; Suchada Indhavivadhana; Thanyarat Wongwananuruk; Kitirat Techatraisak; Chongdee Dangrat; Nutchaya Sa-Nga-Areekul
Journal:  Arch Gynecol Obstet       Date:  2020-01-11       Impact factor: 2.493

Review 3.  Managing dyslipidemia in HIV/AIDS patients: challenges and solutions.

Authors:  Nazik Elmalaika Os Husain; Mohamed H Ahmed
Journal:  HIV AIDS (Auckl)       Date:  2014-12-17

4.  Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study.

Authors:  Vasilios G Athyros; Niki Katsiki; Konstantinos Tziomalos; Thomas D Gossios; Eleni Theocharidou; Eygenia Gkaliagkousi; Panagiotis Anagnostis; Efstathios D Pagourelias; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2013-05-28       Impact factor: 3.318
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.